T1	Participants 60 119	short quadruple therapy for Helicobacter pylori eradication
T2	Participants 698 895	H. pylori-positive patients with gastric or duodenal ulcers or erosive gastritis, treated after failure of dual therapy (proton-pump-inhibitors or ranitidine plus amoxicillin) or for the first time
T3	Participants 897 953	They were assigned to a one week triple standard therapy
T4	Participants 1294 1348	total of 71 patients were treated by quadruple therapy
